These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35820417)

  • 1. Cell-free production of personalized therapeutic phages targeting multidrug-resistant bacteria.
    Emslander Q; Vogele K; Braun P; Stender J; Willy C; Joppich M; Hammerl JA; Abele M; Meng C; Pichlmair A; Ludwig C; Bugert JJ; Simmel FC; Westmeyer GG
    Cell Chem Biol; 2022 Sep; 29(9):1434-1445.e7. PubMed ID: 35820417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.
    Manohar P; Nachimuthu R; Lopes BS
    BMC Microbiol; 2018 Aug; 18(1):97. PubMed ID: 30170558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic characterization of three bacteriophages targeting multidrug resistant clinical isolates of Escherichia, Klebsiella and Salmonella.
    Nepal R; Houtak G; Karki S; Dhungana G; Vreugde S; Malla R
    Arch Microbiol; 2022 May; 204(6):334. PubMed ID: 35585249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of 29 newly isolated bacteriophages as a potential therapeutic agent against IMP-6-producing
    Kondo K; Nakano S; Hisatsune J; Sugawara Y; Kataoka M; Kayama S; Sugai M; Kawano M
    Microbiol Spectr; 2023 Sep; 11(5):e0476122. PubMed ID: 37724861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biological characteristics and genomic information of a bacteriophage against pan-drug resistant
    Qi ZY; Yang SY; Dong SW; Zhao FF; Qin JH; Xiang J
    Zhonghua Shao Shang Za Zhi; 2020 Jan; 36(1):14-23. PubMed ID: 32023713
    [No Abstract]   [Full Text] [Related]  

  • 6. Phage Engineering for Targeted Multidrug-Resistant
    Song J; Liu Z; Zhang Q; Liu Y; Chen Y
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of two bacteriophages with lytic activity against multidrug-resistant Escherichia coli.
    Fu P; Zhao Q; Shi L; Xiong Q; Ren Z; Xu H; Chai S; Xu Q; Sun X; Sang M
    Virus Res; 2021 Jan; 291():198196. PubMed ID: 33098914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Characterization and Efficacy of Bacteriophage Cocktails Infecting
    Manohar P; Tamhankar AJ; Lundborg CS; Nachimuthu R
    Front Microbiol; 2019; 10():574. PubMed ID: 30949158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and Characterization of Novel Phages Targeting Pathogenic
    Li N; Zeng Y; Bao R; Zhu T; Tan D; Hu B
    Front Cell Infect Microbiol; 2021; 11():792305. PubMed ID: 34926329
    [No Abstract]   [Full Text] [Related]  

  • 10. Lytic Phages against ST11 K47 Carbapenem-Resistant Klebsiella pneumoniae and the Corresponding Phage Resistance Mechanisms.
    Fang Q; Zong Z
    mSphere; 2022 Apr; 7(2):e0008022. PubMed ID: 35255715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On-Demand Isolation of Bacteriophages Against Drug-Resistant Bacteria for Personalized Phage Therapy.
    Mattila S; Ruotsalainen P; Jalasvuori M
    Front Microbiol; 2015; 6():1271. PubMed ID: 26617601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of four virulent Klebsiella pneumoniae bacteriophages, and evaluation of their potential use in complex phage preparation.
    Zurabov F; Zhilenkov E
    Virol J; 2021 Jan; 18(1):9. PubMed ID: 33407669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophage Treatment Rescues Mice Infected with Multidrug-Resistant Klebsiella pneumoniae ST258.
    Hesse S; Malachowa N; Porter AR; Freedman B; Kobayashi SD; Gardner DJ; Scott DP; Adhya S; DeLeo FR
    mBio; 2021 Feb; 12(1):. PubMed ID: 33622728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of
    Tan D; Zhang Y; Cheng M; Le S; Gu J; Bao J; Qin J; Guo X; Zhu T
    Viruses; 2019 Nov; 11(11):. PubMed ID: 31752386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterising the biology of novel lytic bacteriophages infecting multidrug resistant Klebsiella pneumoniae.
    Kęsik-Szeloch A; Drulis-Kawa Z; Weber-Dąbrowska B; Kassner J; Majkowska-Skrobek G; Augustyniak D; Lusiak-Szelachowska M; Zaczek M; Górski A; Kropinski AM
    Virol J; 2013 Mar; 10():100. PubMed ID: 23537199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phage Resistance in Multidrug-Resistant Klebsiella pneumoniae ST258 Evolves via Diverse Mutations That Culminate in Impaired Adsorption.
    Hesse S; Rajaure M; Wall E; Johnson J; Bliskovsky V; Gottesman S; Adhya S
    mBio; 2020 Jan; 11(1):. PubMed ID: 31992617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of Leaderless-Bacteriocin-Producing Bacteriophage Targeting E. coli and Neighboring Gram-Positive Pathogens.
    Masuda Y; Kawabata S; Uedoi T; Honjoh KI; Miyamoto T
    Microbiol Spectr; 2021 Sep; 9(1):e0014121. PubMed ID: 34259542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of
    Moses S; Vagima Y; Tidhar A; Aftalion M; Mamroud E; Rotem S; Steinberger-Levy I
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33440682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering bacteriophages for enhanced host range and efficacy: insights from bacteriophage-bacteria interactions.
    Jia HJ; Jia PP; Yin S; Bu LK; Yang G; Pei DS
    Front Microbiol; 2023; 14():1172635. PubMed ID: 37323893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.